Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Vor Biopharma Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Chakraborty Tirtha (Chief Scientific Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 875 shares
@ $2.67, valued at
$2.3k
|
|
| 08/09/2023 |
4
| Jorgensen Nathan D. (CFO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 834 shares
@ $2.67, valued at
$2.2k
|
|
| 08/09/2023 |
4
| Attar Eyal C. (Chief Medical Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 999 shares
@ $2.67, valued at
$2.7k
|
|
| 08/09/2023 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 2,361 shares
@ $2.67, valued at
$6.3k
|
|
| 06/02/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 06/02/2023 |
4
| Resnick Joshua (Director) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 06/02/2023 |
4
| Patterson Matthew R (Director) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 06/02/2023 |
4
| Lubner David Charles (Director) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 06/02/2023 |
4
| Lundberg Sven Ante (Director) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 06/02/2023 |
4
| Beckman Daniella (Director) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 05/10/2023 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 2,361 shares
@ $4.14, valued at
$9.8k
|
|
| 05/10/2023 |
4
| Chakraborty Tirtha (Chief Scientific Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 875 shares
@ $4.14, valued at
$3.6k
|
|
| 05/10/2023 |
4
| Jorgensen Nathan D. (CFO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 834 shares
@ $4.14, valued at
$3.5k
|
|
| 05/10/2023 |
4
| Attar Eyal C. (Chief Medical Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 969 shares
@ $4.14, valued at
$4k
|
|
| 03/02/2023 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 12,657 shares
@ $5.51, valued at
$69.7k
|
|
| 03/02/2023 |
4
| Chakraborty Tirtha (Chief Scientific Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 5,576 shares
@ $5.51, valued at
$30.7k
|
|
| 03/02/2023 |
4
| Jorgensen Nathan D. (CFO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 6,310 shares
@ $5.51, valued at
$34.8k
|
|
| 02/08/2023 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 128,750 shares
@ $0
Granted 257,500 options to buy
@ $5.55, valued at
$1.4M
|
|
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 11,627,907 shares
@ $4.3, valued at
$50M
|
|
| 10/12/2022 |
4
| Attar Eyal C. (Chief Medical Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 364,000 options to buy
@ $3.77, valued at
$1.4M
|
|
| 09/15/2022 |
4
| ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 172,500 shares
@ $0
Granted 172,500 options to buy
@ $4.97, valued at
$857.3k
|
|
| 09/06/2022 |
4
| Chakraborty Tirtha (Chief Scientific Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 76,000 shares
@ $0
Granted 76,000 options to buy
@ $5.31, valued at
$403.6k
|
|
| 09/06/2022 |
4
| Jorgensen Nathan D. (CFO) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 86,000 shares
@ $0
Granted 86,000 options to buy
@ $5.31, valued at
$456.7k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| 5AM Ventures VI, L.P. (10% Owner) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Sold 238,870 shares
@ $15.3, valued at
$3.7M
Sold 91,836 shares
@ $15.3, valued at
$1.4M
|
|
|
|
|